Addus HomeCare announces pricing of initial public offering; grants option to purchase additional 810,000 shares

NewsGuard 100/100 Score

Addus HomeCare Corporation announced today that it has priced the initial public offering of 5,400,000 shares of its common stock at $10.00 per share. Addus shares will begin trading on October 28, 2009 on the Nasdaq Global Market under the ticker symbol "ADUS". The closing of the offering is scheduled to take place on November 2, 2009. Addus expects to receive net proceeds from the offering, after deducting the underwriting discount and estimated offering expenses, of approximately $50.2 million.

Addus has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares to cover over-allotments, if any.

Robert W. Baird & Co. and Oppenheimer & Co. acted as joint book-running managers, and Stephens Inc. acted as co-manager. The shares of common stock are being offered only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained for free by visiting the Securities and Exchange Commission website at http://www.sec.gov. Alternatively, you may obtain a copy of the final prospectus by contacting Robert W. Baird & Co. Incorporated, 777 East Wisconsin Avenue, Milwaukee, WI 53202, or by telephone at (800) 792-2473 or Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 300 Madison Avenue, 4th Floor, New York, NY 10017, by telephone at (212) 667-8563, or via email at [email protected].

A registration statement relating to shares of the common stock of Addus has been filed and declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy shares of common stock of Addus, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.